Q-linea AB Stock: price and insider trades · Sweden

Q-linea AB, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. Between 18 October 2025 and 18 October 2026, 6 insiders published 10 filings.

Both sides are active: 3 purchases worth €14k and 3 sales worth €7,561, from 3 insiders and 3 insiders respectively. Taken together, the purchases exceed the sales by €6,832. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The buyers include 2 senior executives and 1 board member. One trade stands out by size: a purchase of €6,175 from Henrik Jacobson, disclosed on 4 June 2026, or 0.021% of market capitalisation.

With 10 filings in twelve months, the company is more active than the median of 7 filings across the 890 companies we follow on the same exchange. Looking back to 2025, when coverage begins, insiders filed 4 purchases and 4 sales.

Within a 30-day window, 2 purchases overlapped with buying by a second insider. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The last insider purchase was made public on 9 June 2026, 131 days ago. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19).

In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.